32281-65-5Relevant articles and documents
Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
-
Page/Page column 29; 30, (2015/09/28)
This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds in combination with substituted imidazole compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to an animal in need thereof.
HISTONE DEMETHYLASE INHIBITORS
-
Paragraph 00551, (2014/07/08)
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
COMPOSITIONS COMPRISING AN ARYL PYRAZOLE AND A SUBSTITUTED IMIDAZOLE, METHODS AND USES THEREOF
-
Page/Page column 41-42, (2013/06/05)
This invention relates to compositions for combating parasites in animals, comprising 1-arylpyrazole compounds in combination with substituted imidazole compounds. This invention also provides for an improved methods for eradicating, controlling, and preventing parasite infestation in an animal comprising administering the compositions of the invention to an animal in need thereof.
De novo synthesis of (+)-isofregenedol
Riou, Maxime,Barriault, Louis
experimental part, p. 7436 - 7439 (2009/05/07)
(Chemical Equation Presented) An efficient enantioselective synthesis of (+)-isofregenedol was achieved in 13 steps from commercially available cyclohexene oxide without the use of protecting groups. The tetrahydronaphthalenic core of isofregenedol was ob
Synthesis of (±)-7,8- and 5,6-dimethyl-2-(2-hydroxyisopropyl) tetralins
Kadam,Desai,Mane
, p. 752 - 756 (2007/10/03)
7,8-Dimethyl-l-tetralone 4 on sodium borohydride reduction followed by Vilsmeier-Haack reaction furnishes 7, 8-dimethyl-3,4-dihydro-2-naphthaldehyde 10. Reduction of 10 followed by oxidation with Jones reagent yields 7, 8-dimethyl-1,2,3,4-tetrahydro-2-naphthoic acid 12 which on treatment with excess of methyllithium affords 7, 8-dimethyl-2-(2-hydroxyisopropyl) tetralin 2. 5,6-dimethyl-l-tetralone 5 is converted into the 5,6-dimethyl-2-(2-hydroxyisopropyl)tetralin 3 by following similar set of reactions as described above.
Synthesis of 1,1,5,6-tetramethyl-and 7-isopropyl-1,1-dimethyl-1,2,3,4-tetrahydronaphthalene
Mane, Ramchandra Bhimrao,Kadam, Abhijit Jaysingrao,Salunkhe, Rajashree Sandeep
, p. 527 - 532 (2007/10/03)
4-(2,3-Dimethylphenyl)butanoic acid (4) was treated with excess of methyllithium to yield 5-(2,3-dimethylphenyl)-2-methylpentan-2-ol (6) which was cyclodehydrated using Dowex 50W-X8 resin, trifluoroacetic acid or polyphosphoric acid (PPA) to furnish 1,1,5,6-tetramethyl-1,2,3,4-tetrahydronaphthalene (1). The acid 4 was cyclized with PPA to furnish 5,6-dimethyl-3,4-dihydronaphthalen-1(2H)-one (5) which was converted into 1 by reaction with dimethylzinc and titanium tetrachloride. 4-(4-Isopropylphenyl)butanoic acid (7) on esterification followed by Grignard reaction with methylmagnesium iodide furnished 5-(4-isopropylphenyl)-2-methylpentan-2-ol (9), which was cyclodehydrated as above to yield 7-isopropyl-1,1-dimethyl-1,2,3,4-tetrahydronaphthalene (2).
Synthesis of (+/-)-7,8- and 5,6-Dimethyl-2-(2-hydroxyisopropyl)tetralins, Stress Metabolites from Tobaccco Mosaic Virus Infested Tobacco
Murali, D.,Rao, G. S. Krishna
, p. 843 - 846 (2007/10/02)
Two stress metabolites (1 and 2) produced by tobacco leaves inoculated with tobacco mosaic virus have been synthesized from the tetrahydronaphthoates (9 and 10), elaborated in turn from 2,3-dimethylbenzaldehyde (6) and 4-(2,3-dimethylphenyl)butanoic acic